Osteoprotective effects of flavonoids: Evidence from in vivo and in vitro studies (Review)
- Authors:
- Lili Cao
- Jiawei Wang
- Yujuan Zhang
- Feng Tian
- Chunfang Wang
-
Affiliations: School and Hospital of Stomatology, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Experimental Animal Center, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Taiyuan, Shanxi 030001, P.R. China - Published online on: April 26, 2022 https://doi.org/10.3892/mmr.2022.12716
- Article Number: 200
This article is mentioned in:
Abstract
 |
|
Christiansen C: Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Osteoporosis Int. 295:914–915. 1987. | |
|
Management of osteoporosis in postmenopausal women, . 2010 position statement of The North American Menopause Society. Menopause. 17:25–56. 2010. View Article : Google Scholar | |
|
Langdahl BL and Harslof T: Medical treatment of osteoporotic vertebral fractures. Ther Adv Musculoskel. 3:17–29. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Leong KH: Medical treatment of osteoporosis-increasing options. Ann Acad Med Singap. 31:43–47. 2002.PubMed/NCBI | |
|
Nahas NE, Samy AM and Omer MO: Global, regional, and national burden of bone fractures in 204 countries and territories, 1990-2019: A systematic analysis from the global burden of disease study 2019. Lancet Healthy Longev. 2:e580–e592. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Harborne JB and Baxter H: The Handbook of Natural Flavonoids. 2:pp18001999. | |
|
Kimira M, Arai Y, Shimoi K and Watanabe S: Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol. 8:168–175. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Cushnie T and Lamb AJ: Antimicrobial activity of flavonoids. Int J Antimicrob Ag. 26:343–356. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SY, Lee JY, Park YD, Kang KL, Lee JC and Heo JS: Hesperetin alleviates the inhibitory effects of high glucose on the osteoblastic differentiation of periodontal ligament stem cells. PLoS One. 8:e675042013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang P, Dai KR and Yan SG: Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol. 607:1–5. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Black DM and Rosen CJ: Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 374:254–262. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 843:1–129. 1994.PubMed/NCBI | |
|
Kanis JA, Melton LJ III, Christiansen C, Johnston CC and Khaltaev N: The diagnosis of osteoporosis. J Bone Miner Res. 9:1137–1141. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Johnell O, Kanis JA, Oden A, Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, et al: Predictive value of BMD for hip and other fractures. J Bone Miner Res. 20:1185–1194. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Jianning Y: Osteoporosis prevalence and community-based diagnosis and management of osteoporosis-related chronic pain in China. Chin Gen Pract. 23:2223–2228. 2020. | |
|
Office of the Surgeon General (US), . Bone Health and Osteoporosis: A report of the surgeon general. Rockville (MD): Office of the Surgeon General (US); 2004 | |
|
Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM and Cooper C: The epidemiology of osteoporosis. Br Med Bull. 133:105–117. 2020.PubMed/NCBI | |
|
van Staa T, Dennison EM, Leufkens H and Cooper C: Epidemiology of fractures in England and Wales. Bone. 29:517–522. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Ensrud KE and Crandall CJ: Osteoporosis. Ann Intern Med. 167:ITC17–ITC32. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dewan N, Macdermid JC, Grewal R and Beattie K: Risk factors predicting subsequent falls and osteoporotic fractures at 4 years after distal radius fracture-a prospective cohort study. Arch Osteoporos. 13:322018. View Article : Google Scholar : PubMed/NCBI | |
|
Balasuriya B and Rupasinghe H: Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Funct Foods Health Dis. 5:172–188. 2010. | |
|
Wang TY, Li Q and Bi KS: Bioactive flavonoids in medicinal plants: Structure, activity and biological fate. Asian J Pharm Sci. 13:12–23. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Alvarez-Arellano L, Salazar-García M and Corona JC: Neuroprotective effects of quercetin in pediatric neurological diseases. Molecules. 25:55972020. View Article : Google Scholar : PubMed/NCBI | |
|
Manca ML, Castangia I, Caddeo C, Pando D, Escribano E, Valenti D, Lampis S, Zaru M, Fadda AM and Manconi M: Improvement of quercetin protective effect against oxidative stress skin damages by incorporation in nanovesicles. Colloids Surf B Biointerfaces. 123:566–574. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Andres S, Pevny S, Ziegenhagen R, Bakhiya N, Schäfer B, Hirsch-Ernst KI and Lampen A: Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 622018.doi: 10.1002/mnfr.201700447. PubMed/NCBI | |
|
David A, Arulmoli R and Parasuraman S: Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn Rev. 10:84–89. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mehrbod P, Abdalla MA, Fotouhi F, Heidarzadeh M, Aro AO, Eloff JN, McGaw LJ and Fasina FO: Immunomodulatory properties of quercetin-3-O-α-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus. BMC Complement Altern Med. 18:1842018. View Article : Google Scholar : PubMed/NCBI | |
|
Flores IR, Vásquez-Murrieta MS, Franco-Hernández MO, Márquez-Herrera CE, Ponce-Mendoza A and Del Socorro López-Cortéz M: Bioactive compounds in tomato (Solanum lycopersicum) variety saladette and their relationship with soil mineral content. Food Chem. 344:1286082021. View Article : Google Scholar : PubMed/NCBI | |
|
Torres N, Martínez-Lüscher J, Porte E, Yu R and Kurtural SK: Impacts of leaf removal and shoot thinning on cumulative daily light intensity and thermal time and their cascading effects of grapevine (Vitis vinifera L.) berry and wine chemistry in warm climates. Food Chem. 343:1284472020. View Article : Google Scholar : PubMed/NCBI | |
|
Maria P, Vivian O, Tatiana P and Sandra P: Physicochemical stability, antioxidant activity, and acceptance of beet and orange mixed juice during refrigerated storage. Beverages. 3:362017. View Article : Google Scholar | |
|
Santiago B, Calvo AA, Gullón B, Feijoo G, Moreira MT and González-García S: Production of flavonol quercetin and fructooligosaccharides from onion (Allium cepa L.) waste: An environmental life cycle approach. Chem Eng J. 392:1237722020. View Article : Google Scholar | |
|
Ribes-Moya AM, Adalid AM, Raigón MD, Hellín P, Fita A and Rodríguez-Burruezo A: Variation in flavonoids in a collection of peppers (Capsicum sp.) under organic and conventional cultivation: Effect of the genotype, ripening stage, and growing system. J Sci Food Agr. 100:2208–2223. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun J, Janisiewicz WJ, Takeda F, Evans B, Wayne JM, Mengliang Z, Liangli Y and Chen P: Effect of nighttime UV-C irradiation of strawberry plants on phenolic content of fruit: Targeted and non-targeted metabolomic analysis. J Berry Res. 10:365–380. 2020. View Article : Google Scholar | |
|
Zhou W, Liang X, Dai P, Chen Y, Zhang Y, Zhang M, Lu L, Jin C and Lin X: Alteration of phenolic composition in lettuce (Lactuca sativa L.) by reducing nitrogen supply enhances its anti-proliferative effects on colorectal cancer cells. Int J Mol Sci. 20:42052019. View Article : Google Scholar : PubMed/NCBI | |
|
Formica JV and Regelson W: Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol. 33:1061–1080. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Nugroho A, Hesty H, Choi JS and Park HJ: Identification and quantification of flavonoids in Carica papaya leaf and peroxynitrite-scavenging activity. Asian Pac J Trop Biomed. 7:208–213. 2017. View Article : Google Scholar | |
|
Bolling BW, Mckay DL and Blumberg JB: The phytochemical composition and antioxidant actions of tree nuts. Asia Pac J Clin Nutr. 19:117–123. 2010.PubMed/NCBI | |
|
Stavric B: Quercetin in our diet: From potent mutagen to probable anticarcinogen. Clin Biochem. 27:245–248. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Batiha ES, Beshbishy AM, Ikram M, Mulla ZS, El-Hack MEA, Taha AE, Algammal AM and Elewa YHA: The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: Quercetin. Foods. 9:3742020. View Article : Google Scholar : PubMed/NCBI | |
|
Beecher GR, Warden BA and Merken H: Analysis of tea polyphenols. Proc Soc Exp Biol Med. 220:267–270. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Hirpara KV, Aggarwal P, Mukherjee AJ, Joshi N and Burman AC: Quercetin and its derivatives: Synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med Chem. 9:138–161. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Boots AW, Haenen GR and Bast A: Health effects of quercetin: From mechanism to nutraceutical. Eur J Pharmacol. 585:325–337. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yamaguchi M and Weitzmann MN: Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts. Int J Mol Med. 28:521–525. 2011.PubMed/NCBI | |
|
Chen M, Wu J, Luo Q, Mo S, Lyu Y, Wei Y and Dong J: The Anticancer properties of Herba Epimedii and its main bioactive Componentsicariin and Icariside II. Nutrients. 8:5632016. View Article : Google Scholar : PubMed/NCBI | |
|
Huang W, Zeng S, Xiao G, Wei G, Liao S, Chen J, Sun W, Lv H and Wang Y: Elucidating the biosynthetic and regulatory mechanisms of flavonoid-derived bioactive components in Epimedium sagittatum. Front Plant Sci. 6:6892015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang KC: The pharmacology of Chinese herbs. Pharmacol Chin Herbs. 1993. | |
|
Makarova MN, Pozharitskaya ON, Shikov AN, Tesakova SV, Makarov VG and Tikhonov VP: Effect of lipid-based suspension of Epimedium koreanum Nakai extract on sexual behavior in rats. J Ethnopharmacol. 114:412–416. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ma H, He X, Yang Y, Li M, Hao D and Jia Z: The genus Epimedium: An ethnopharmacological and phytochemical review. J Ethnopharmacol. 134:519–541. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Xie X, Pei F, Wang H, Tan Z, Yang Z and Kang P: Icariin: A promising osteoinductive compound for repairing bone defect and osteonecrosis. J Biomater Appl. 30:290–299. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Wang D, Yang D, Zhen W, Zhang J and Peng S: The effect of icariin on bone metabolism and its potential clinical application. Osteoporos Int. 29:535–544. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
He C, Wang Z and Shi J: Pharmacological effects of icariin. Adv Pharmacol. 87:179–203. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Gary AB and McIntosh C: Radioimmunoassay for the quantitative determination of hesperidin and analysis of its distribution in Citrus sinensis. Phytochemistry. 27:249–254. 1988. View Article : Google Scholar | |
|
Rady H: Pharmacographia: A History of the principal Drugs of Vegetable Origin met with in Great Britain and British India. Nature. 11:42–44. 1874. View Article : Google Scholar | |
|
Garg A, Garg S, Zaneveld LJ and Singla AK: Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother Res. 15:655–669. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Parhiz H, Roohbakhsh A, Soltani F, Rezaee R and Iranshahi M: Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytother Res. 29:323–331. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li R, Cai L, Xie XF, Peng L, Wu TN and Li J: 7,3′-dimethoxy hesperetin inhibits inflammation by inducing synovial apoptosis in rats with adjuvant-induced arthritis. Immunopharmacol Immunotoxicol. 35:139–146. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Z, Liu Z, Wang J and Zhu H: Antioxidative effects of hesperetin against lead acetate-induced oxidative stress in rats. Indian J Pharmacol. 45:395–398. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Itoh K, Masuda M, Naruto S, Murata K and Matsuda H: Antiallergic activity of unripe Citrus hassaku fruits extract and its flavanone glycosides on chemical substance-induced dermatitis in mice. J Nat Med. 63:443–450. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Trzeciakiewicz A, Habauzit V, Mercier S, Lebecque P, Davicco MJ, Coxam V, Demigne C and Horcajada MN: Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway. J Nutr Biochem. 21:424–431. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ashraful AM, Nusrat S, Mahbubur RM, Uddin SJ, Reza HM and Sarker SD: Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. 5:404–417. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
E. P. O. Additives and Products or Substances used in Animal Feed, . Scientific Opinion on the safety and efficacy of naringin when used as a sensory additive for all animal species. EfSA J. 9:24162011. | |
|
Joshi R, Kulkarni YA and Wairkar S: Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Life Sci. 215:43–56. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Yin L, Li Y, Liu P and Cui Q: Preventive effects of puerarin on alcohol-induced osteonecrosis. Clin Orthop Relat Res. 466:1059–1067. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Akintunde JK, Akintola TE, Hammed MO, Amoo CO, Adegoke AM and Ajisafe LO: Naringin protects against Bisphenol-A induced oculopathy as implication of cataract in hypertensive rat model. Biomed Pharmacother. 126:1100432020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang YF, Meng NN, Li HZ, Wen YJ, Liu JT, Zhang CL, Yuan XH and Jin XD: Effect of naringin on oxidative stress and endoplasmic reticulum stress in diabetic cardiomyopathy. Zhongguo Zhong Yao Za Zhi. 43:596–602. 2018.(In Chinese). PubMed/NCBI | |
|
Choi JH and Yun JW: Chrysin induces brown fat-like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes. Nutrition. 32:1002–1010. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mohammadian F, Abhari A, Dariushnejad H, Nikanfar A, Pilehvar-Soltanahmadi Y and Zarghami N: Effects of Chrysin-PLGA-PEG nanoparticles on proliferation and gene expression of miRNAs in gastric cancer cell line. Iran J Cancer Prev. 9:e41902016. View Article : Google Scholar : PubMed/NCBI | |
|
Kang MK, Park SH, Kim YH, Lee EJ, Antika LD, Kim DY, Choi YJ and Kang YH: Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice. Acta Pharmacol Sin. 38:1129–1140. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shoieb SM, Esmat A, Khalifa AE and Abdel-Naim AB: Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats. Food Chem Toxicol. 111:650–659. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zeinali M, Rezaee SA and Hosseinzadeh H: An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substances. Biomed Pharmacother. 92:998–1009. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Vedagiri A and Thangarajan S: Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid β25-35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer's disease. Neuropeptides. 58:111–125. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Khan R, Khan AQ, Qamar W, Lateef A, Ali F, Rehman MU, Tahir M, Sharma S and Sultana S: Chrysin abrogates cisplatin-induced oxidative stress, p53 expression, goblet cell disintegration and apoptotic responses in the jejunum of Wistar rats. Br J Nutr. 108:1574–1585. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Khan MS, Devaraj H and Devaraj N: Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats. Toxicol Appl Pharmacol. 251:85–94. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Shen Y, Tian P, Li D, Wu Y, Wan C, Yang T, Chen L, Wang T and Wen F: Chrysin suppresses cigarette smoke-induced airway inflammation in mice. Int J Clin Exp Med. 8:2001–2008. 2015.PubMed/NCBI | |
|
Rehman MU, Ali N, Rashid S, Jain T, Nafees S, Tahir M, Khan AQ, Lateef A, Khan R, Hamiza OO, et al: Alleviation of hepatic injury by chrysin in cisplatin administered rats: Probable role of oxidative and inflammatory markers. Pharmacol Rep. 66:1050–1059. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ravishankar D, Salamah M, Attina A, Pothi R, Vallance TM, Javed M, Williams HF, Alzahrani EMS, Kabova E, Vaiyapuri R, et al: Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacy. Sci Rep. 7:57382017. View Article : Google Scholar : PubMed/NCBI | |
|
Shibata S, Murakami T, Nishikawa Y and Harada M: The constituents of pueraria root. Chem Pharm Bull. 7:134–136. 1959. View Article : Google Scholar | |
|
Keung WM and Vallee BL: Kudzu root: An ancient Chinese source of modern antidipsotropic agents. Phytochemistry. 47:499–506. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT and Aldrich RW: Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature. 407:870–876. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC and Cheng JT: Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod. 66:788–792. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Hao LN, Zhang YQ, Shen YH, Wang ZY and Wang YH: Inducible nitric oxide synthase and Fas/FasL with C3 expression of mouse retinal pigment epithelial cells in response to stimulation by peroxynitrite and antagonism of puerarin. Chin Med J. 124:2522–2529. 2011.PubMed/NCBI | |
|
Shao HM, Tang YH, Jiang PJ, Zhu HQ, Zhang YC, Ji JM, Ji O and Shen Q: Inhibitory effect of flavonoids of puerarin on proliferation of different human acute myeloid leukemia cell lines in vitro. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 18:296–299. 2010.(In Chinese). PubMed/NCBI | |
|
Cheng Y, Zhu G, Guan Y, Liu Y, Hu Y and Li Q: Protective effects of puerarin against 1-methyl-4-phenylpyridinium-induced mitochondrial apoptotic death in differentiated SH-SY5Y cells. Zhongguo Zhong Yao Za Zhi. 36:1222–1226. 2011.(In Chinese). PubMed/NCBI | |
|
Zou Y, Hong B, Fan L, Zhou L, Liu Y, Wu Q, Zhang X and Dong M: Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: Involvement of the GSK-3β/Nrf2 signaling pathway. Free Radical Res. 47:55–63. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Song JL, Baek HJ, Chang HL and Kim HP: Antiinflammatory activity of isoflavonoids from Pueraria radix and biochanin A derivatives. Arch Pharm Res. 17:31–35. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Overstreet DH, Kralic JE, Morrow AL, Ma ZZ, Zhong ZM and Lee D: NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT2C agonists. Pharmacol Biochem Behav. 75:619–625. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yong PH and Jeong HG: Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: Estrogen receptor-dependent up-regulation of PI3K/Akt and HO-1. Toxicol Appl Pharmacol. 233:371–381. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cho HJ, Jun HJ, Ji HL, Jia Y, Hoang MH, Shim JH, Park KH and Lee SJ: Acute effect of high-dose isoflavones from Pueraria lobata (Willd.) Ohwi on lipid and bone metabolism in ovariectomized mice. Phytother Res. 26:1864–1871. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Wang Z, Duan N, Zhu G, Schwarz EM and Xie C: Osteoblast-osteoclast interactions. Connect Tissue Res. 59:99–107. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Compston JE, McClung MR and Leslie WD: Osteoporosis. Lancet. 393:364–376. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lerner UH, Kindstedt E and Lundberg P: The critical interplay between bone resorbing and bone forming cells. J Clin Periodontol. 46 (Suppl 21):S33–S51. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Urist MR: Bone: Formation by autoinduction. Science. 150:893–899. 1965. View Article : Google Scholar : PubMed/NCBI | |
|
Luyten FP, Cunningham NS, Ma S, Muthukumaran N, Hammonds RG, Nevins WB, Woods WI and Reddi AH: Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem. 264:13377–13380. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM and Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science. 242:1528–1534. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Xu C and Di C: The BMP signaling and in vivo bone formation. Gene. 357:1–8. 2005. View Article : Google Scholar | |
|
Hinck AP, Mueller TD and Springer TA: Structural biology and evolution of the TGF-β family. Cold Spring Harb Perspect Biol. 8:a221032016. View Article : Google Scholar : PubMed/NCBI | |
|
von Bubnoff A and Cho KW: Intracellular BMP signaling regulation in vertebrates: Pathway or network? Dev Biol. 239:1–14. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Nohe A, Keating E, Knaus P and Petersen NO: Signal transduction of bone morphogenetic protein receptors. Cell Signal. 16:291–299. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Javed A, Afzal F, Bae JS, Gutierrez S, Zaidi K, Pratap J, van Wijnen AJ, Stein JL, Stein GS and Lian JB: Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation. Cells Tissues Organs. 189:133–137. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Phimphilai M, Zhao Z, Boules H, Roca H and Franceschi RT: BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Mineral Res. 21:637–646. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tan X, Weng T, Zhang J, Wang J, Li W, Wan H, Lan Y, Cheng X, Hou N, Liu H, et al: Smad4 is required for maintaining normal murine postnatal bone homeostasis. J Cell Sci. 120:2162–2170. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Liang W and Luo Z, Ge S, Li M, Du J, Yang M, Yan M, Ye Z and Luo Z: Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia. Eur J Pharmacol. 670:317–324. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou C and Lin Y: Osteogenic differentiation of adipose-derived stem cells promoted by quercetin. Cell Prolif. 47:124–132. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sharan K, Mishra JS, Swarnkar G, Siddiqui JA, Khan K, Kumari R, Rawat P, Maurya R, Sanyal S and Chattopadhyay N: A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: The role of aryl hydrocarbon receptor as a mediator of osteogenic action. J Bone Miner Res. 26:2096–2111. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liu M, Li Y and Yang ST: Effects of naringin on the proliferation and osteogenic differentiation of human amniotic fluid-derived stem cells. J Tissue Eng Regen Med. 11:276–284. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Menon AH, Soundarya SP, Sanjay V, Chandran SV, Balagangadharan K and Selvamurugan N: Sustained release of chrysin from chitosan-based scaffolds promotes mesenchymal stem cell proliferation and osteoblast differentiation. Carbohyd Polym. 195:356–367. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Willert K and Nusse R: Beta-catenin: A key mediator of Wnt signaling. Curr Opin Genet Dev. 8:95–102. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Clevers H and Nusse R: Wnt/β-catenin signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kestler HA and Kühl M: From individual Wnt pathways towards a Wnt signalling network. Philos Trans R Soc Lond B Biol Sci. 363:1333–1347. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lin FX, Du SX, Liu DZ, Hu QX, Yu GY, Wu CC, Zheng GZ, Xie D, Li XD and Chang B: Naringin promotes osteogenic differentiation of bone marrow stromal cells by up-regulating Foxc2 expression via the IHH signaling pathway. Am J Transl Res. 8:5098–5107. 2016.PubMed/NCBI | |
|
Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Mercedes SS, Diniz FF, Gomes GN and Diana B: The Mitogen-activated protein kinase (MAPK) pathway: Role in immune evasion by trypanosomatids. Front Microbiol. 7:1832016.PubMed/NCBI | |
|
Arthur JS and Ley SC: Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 13:679–692. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ronkina N and Gaestel M: MAPK-activated protein kinases: Servant or partner? Annu Rev Biochem. Feb 18–2022.(Epub ahead of print). doi: 10.1146/annurev-biochem-081720-114505. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Y, Xia L, Zhou Y, Xu Y and Jiang X: Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner. Cell Prolif. 48:375–384. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Liu L, Zheng J, Yang Y, Ni L, Chen H and Yu D: Hesperetin alleviated glucocorticoid-induced inhibition of osteogenic differentiation of BMSCs through regulating the ERK signaling pathway. Med Mol Morphol. 54:1–7. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xue D, Chen E, Zhang W, Gao X, Wang S, Zheng Q, Pan Z, Li H and Liu L: The role of hesperetin on osteogenesis of human mesenchymal stem cells and its function in bone regeneration. Oncotarget. 8:21031–21043. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Yang Y, Zhou S, Gong X, Dai Q, Zhang P and Jiang L: Puerarin Stimulates osteogenic differentiation and bone formation through the ERK1/2 and p38-MAPK signaling pathways. Curr Mol Med. 17:488–496. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Franke TF, Hornik CP, Segev L, Shostak GA and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene. 22:8983–8998. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lien EC, Dibble CC and Toker A: PI3K signaling in cancer: Beyond AKT. Curr Opin Cell Biol. 45:62–71. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M, Ando T, Koizumi K, Endoh T, Sawada K, et al: A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood. 96:941–949. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Gu YX, Du J, Si MS, Mo JJ, Qiao SC and Lai HC: The roles of PI3K/Akt signaling pathway in regulating MC3T3-E1 preosteoblast proliferation and differentiation on SLA and SLActive titanium surfaces. J Biomed Mater Res A. 101:748–754. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xi JC, Zang HY, Guo LX, Xue HB, Liu XD, Bai YB and Ma YZ: The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis. J Recept Signal Transduct Res. 35:640–645. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhai YK, Guo XY, Ge BF, Zhen P, Ma XN, Zhou J, Ma HP, Xian CJ and Chen KM: Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K-AKT-eNOS-NO-cGMP-PKG. Bone. 66:189–198. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lv H, Che T, Tang X, Liu L and Cheng J: Puerarin enhances proliferation and osteoblastic differentiation of human bone marrow stromal cells via a nitric oxide/cyclic guanosine monophosphate signaling pathway. Mol Med Rep. 12:2283–2290. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Yan M, Yu QF, Yang PF, Zhang HD, Sun YH, Zhang ZF and Gao YF: Puerarin prevents LPS-induced osteoclast formation and bone loss via inhibition of Akt activation. Biol Pharm Bull. 39:2028–2035. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Simonet WS, Lacey DL, Dunstan CR, Kelley MC and Boyle WJ: Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 89:309–319. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165–176. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Tan JW, Huang L, Gao XH, Laird R, Liu D, Wysocki S and Zheng MH: Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand. Bone. 15:2178–2186. 2000.PubMed/NCBI | |
|
Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, et al: The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol. 145:527–538. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, et al: Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun. 247:610–615. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, et al: Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 139:1329–1337. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Kostenuik P and Shalhoub V: Osteoprotegerin: A physiological and pharmacological inhibitor of bone resorption. Curr Pharm Design. 7:613–635. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hofbauer LC, Kühne CA and Viereck V: The OPG/RANKL/RANK system in metabolic bone diseases. J Musculoskelet Neuronal Interact. 4:268–275. 2004.PubMed/NCBI | |
|
Yuan SY, Sheng T, Qi L, Zhang YL, Liu XM, Ma T, Zheng H, Yan Y, Ishimi Y and Wang XX: Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. Chin J Nat Med. 14:265–269. 2016.PubMed/NCBI | |
|
Shan Z, Cheng N, Huang R, Zhao B and Zhou Y: Puerarin promotes the proliferation and differentiation of MC3T3-E1 cells via microRNA106b by targeting receptor activator of nuclear factor-κB ligand. Exp Ther Med. 15:55–60. 2018.PubMed/NCBI | |
|
Turner RT, Maran A, Lotinun S, Hefferan T and Sibonga JD: Animal models for osteoporosis. Rev Endocr Metab Disord. 2:117–127. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Huo JF, Zhang ML, Wang XX and Zou DH: Chrysin induces osteogenic differentiation of human dental pulp stem cells. Exp Cell Res. 400:1124662021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu H, Li W, Ge X, Jia S and Li B: Coadministration of puerarin (low dose) and zinc attenuates bone loss and suppresses bone marrow adiposity in ovariectomized rats. Life Sci. 166:20–26. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Bao Y, Xiang W, Jing XZ, Guo JC, Yao XD, Wang R and Guo FJ: Icariin regulates the bidirectional differentiation of bone marrow mesenchymal stem cells through canonical Wnt signaling pathway. Evid Based Complement Alternat Med. 2017:80853252017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Ma W, Wang F, Dong J, Wang D, Sun B and Wang B: Stimulation of Wnt/β-catenin signaling to improve bone development by naringin via interacting with AMPK and Akt. Cell Physiol Biochem. 36:1563–1576. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA. 288:321–333. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, et al: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 282:637–645. 1999. View Article : Google Scholar : PubMed/NCBI |
